K. Angela Macfarlane insider trades
Open-market stock purchases and sales by K. Angela Macfarlane, Director at RenovoRx, Inc, from SEC Form 4 filings since Mar 10, 2022.
Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -27%.
Recent trades
No open-market trades in the last 12 months.
Companies traded
- RNXT RenovoRx, Inc: 1 buy, last Oct 1, 2025
Get free alerts when K. Angela Macfarlane files a new trade →